Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTanfield Regulatory News (TAN)

Share Price Information for Tanfield (TAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.76
Bid: 3.60
Ask: 3.92
Change: 0.00 (0.00%)
Spread: 0.32 (8.889%)
Open: 3.76
High: 0.00
Low: 0.00
Prev. Close: 3.76
TAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Snorkel Investment & Legal Proceedings Update

10 May 2022 07:00

RNS Number : 8316K
Tanfield Group PLC
10 May 2022
 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain

 

 

Tanfield Group Plc

("Tanfield" or the "Company")

 

 

Snorkel Investment & Legal Proceedings Update

 

 

The Board of Tanfield (the "Board") is pleased to update the market on its investment in Snorkel International Holdings LLC ("Snorkel"), the aerial work platform business.

 

Investment Background

 

· Tanfield is a 49% shareholder in the equity of Snorkel following the joint venture between the Company and Xtreme Manufacturing LLC ("Xtreme") (the "Contemplated Transaction"), a company owned by Don Ahern of Ahern Rentals Inc, relating to Snorkel, in October 2013.

 

· The Snorkel investment is valued at £19.1m. The outcome of the US and UK Proceedings referenced below could have an impact on this valuation.

 

· On 22 October 2019, the Company announced that it had received a Summons and Complaint, filed in Nevada (the "US Proceedings") by subsidiaries of Xtreme, relating to the Contemplated Transaction.

 

· On 24 October 2019, the Company announced it had become necessary to issue and serve a claim in the English High Court against Ward Hadaway (the "UK Proceedings"), the solicitor acting for the Company at the time of the Contemplated Transaction, in order to fully protect the Company's rights pending the outcome of the US Proceedings. 

 

· On 26 February 2021, Ward Hadaway was granted permission to join Foulston Siefkin, Tanfield's US based law firm who were retained in 2013 to draft the documents governed by US law relating to the Contemplated Transaction, into the UK Proceedings. As a result, the Company amended its claim to include Foulston Siefkin as a second defendant.

 

 

Highlights

 

· In the final quarter of 2021, Snorkel continued to see a recovery following the impact of the global COVID-19 pandemic with sales of US$41.0m, compared to US$24.2m for the same period in 2020, an increase of 69.2%.

 

· The full year sales of Snorkel in 2021 were US$155.0m, compared to US$110.8m in 2020, an increase of 39.9%.

 

· Both the US and UK Proceedings are continuing. The US Proceedings trial window is currently scheduled to begin in February 2023, with the UK Proceedings trial set for November 2022.

 

 

Business Update

 

Tanfield is a 49% shareholder in the equity of Snorkel following the joint venture between the Company and Xtreme, a company owned by Don Ahern of Ahern Rentals Inc, relating to Snorkel, in October 2013.

 

Snorkel continues to recover from the impact of the global COVID-19 pandemic, which impacted its ability to operate as normal, and has seen sales for the fourth quarter of 2021 increase by 69.2% to US$41.0m as compared to sales in the fourth quarter of 2020 of US$24.2m. Sales for the full year of 2021 increased by 39.9% to US$155.0m as compared to US$110.8m in 2020.

 

Despite the increase in sales in the fourth quarter of 2021, the EBITDA loss for the period remained consistent at US$4.3m as compared to US$4.4m in the fourth quarter of 2020. The Board once again note that the gross profit margin has reduced yet further to around 1.5% for the fourth quarter of 2021, compared to 6.6% for the fourth quarter of 2020. Furthermore, the gross profit margin for the full year of 2021 has reduced to 5.4%, compared to 7.2% in 2020. The Board are unaware of the reason for the reduction and continue to believe that the gross profit margins generally do not appear to be in line with the industry averages. There is currently ongoing work to investigate this.

 

Below is a summary of the consolidated operating statements for the last 5 years:

 

US$000's

2021

2020

2019

2018

2017

 

Net sales

154,951

110,764

220,844

200,507

165,811

Cost of goods sold

146,651

102,783

195,437

175,684

144,828

Gross profit

8,301

7,981

25,408

24,823

20,982

Gross profit margin

5.4%

7.2%

11.5%

12.4%

12.7%

Selling, general, admin & currency costs

17,861

20,565

25,496

21,859

19,621

EBITDA

(9,560)

(12,584)

(89)

2,964

1,361

Depreciation & non-operating costs

2,448

2,240

2,456

3,364

2,360

Net loss

(12,008)

(14,824)

(2,544)

(400)

(999)

 

 

The Board is not able to determine when the market for Snorkel's equipment will return to previous levels. However, it views the ongoing recovery and increases to sales as a positive development and is not aware of any reason why this improving trend should not continue. The Board expects to receive the results for the first quarter of 2022 shortly and will provide a further update at that time.

 

 

US & UK Proceedings

 

Further to the update on 31 January 2022, there are still ongoing deficiencies in the documents produced by Snorkel / Xtreme in the US Proceedings which continue to cause delays. Despite the Board's best efforts to have Snorkel / Xtreme resolve these deficiencies, it nevertheless became necessary to move back the US Proceedings trial window once more until after the UK Proceedings trial in November 2022. The US Proceeding trial window is therefore currently scheduled to begin in February 2023.

 

On 31 January 2022, the Company announced that it had amended its claim in the UK Proceedings to include Foulston Siefkin as a second defendant. Following this amendment, further pleadings have been exchanged and the claim continues to progress towards trial in November 2022. One of the next stages before trial is the preparation of expert accountancy evidence which seeks to value the Snorkel division at the time of the Contemplated Transaction. The Company has recently, as part of its disclosure obligations, provided the defendants with an appraisal report of the tangible and intangible assets of Snorkel at the time of the Contemplated Transaction, prepared in 2014 by independent experts in the field for Xtreme, which the Board understand is the basis for the $45.5m net fair market value that Snorkel / Xtreme declared was contributed by Tanfield as part of the Contemplated Transaction. The Board therefore continues to believe that the value of the Snorkel division at the time of the Contemplated Transaction was substantial.

 

The Board believes that a positive outcome to either or both of the US and UK Proceedings is a reasonable expectation, and the Company will continue to vigorously defend and advance its position in both proceedings, whilst continuing to seek advice. 

 

 

Further updates will be provided to Shareholders as and when appropriate.

 

 

 

For further information:

 

Tanfield Group Plc 020 7220 1666

Daryn Robinson

 

WH Ireland Limited - Nominated Advisor / Broker

James Joyce / Megan Liddell 020 7220 1666

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSSMFIUEESESI
Date   Source Headline
4th Feb 20159:11 amRNSHolding(s) in Company
3rd Feb 20152:31 pmRNSGrant of Options
27th Jan 20157:01 amRNSSmith Investment Update
30th Dec 201410:51 amRNSHolding(s) in Company
16th Dec 20144:40 pmRNSSecond Price Monitoring Extn
16th Dec 20144:35 pmRNSPrice Monitoring Extension
8th Dec 20147:00 amRNSExercise of options and Director's dealing
5th Dec 20144:40 pmRNSSecond Price Monitoring Extn
5th Dec 20144:35 pmRNSPrice Monitoring Extension
2nd Dec 20148:31 amRNSHolding(s) in Company
27th Nov 201411:55 amRNSHolding(s) in Company
25th Nov 20147:00 amRNSIssue of Shares
18th Nov 20147:00 amRNSSnorkel Investment Update
17th Nov 20147:00 amRNSSmith Investment Update
17th Oct 20147:13 amRNSInvestment Update
16th Oct 20144:40 pmRNSSecond Price Monitoring Extn
16th Oct 20144:35 pmRNSPrice Monitoring Extension
15th Oct 20143:29 pmRNSHolding(s) in Company
15th Oct 20142:07 pmRNSHolding(s) in Company
30th Sep 201411:56 amRNSResult of AGM
3rd Sep 20145:32 pmRNSNotice of AGM
21st Aug 20147:00 amRNSInterim Results
14th Aug 20143:54 pmRNSIssue of Equity
24th Jul 20144:40 pmRNSSecond Price Monitoring Extn
24th Jul 20144:35 pmRNSPrice Monitoring Extension
22nd Jul 20145:08 pmRNSHolding(s) in Company
14th Jul 20147:00 amRNSAppointment of Joint Broker
11th Jul 20147:57 amRNSInvestment Update
2nd Jun 20147:00 amRNSFinal Results for the year ending 31 December 2013
30th May 20141:01 pmRNSUpdate re. Final Results
20th May 20147:00 amRNSSmith Investment Update
12th May 20147:00 amRNSSmith Electric Vehicles Update Announcement
31st Mar 20144:35 pmRNSPrice Monitoring Extension
17th Mar 20143:37 pmRNSHolding(s) in Company
14th Mar 20144:40 pmRNSSecond Price Monitoring Extn
14th Mar 20144:35 pmRNSPrice Monitoring Extension
14th Mar 20147:00 amRNSInvestment Update
25th Feb 20144:40 pmRNSSecond Price Monitoring Extn
25th Feb 20144:35 pmRNSPrice Monitoring Extension
12th Feb 20144:35 pmRNSPrice Monitoring Extension
17th Dec 201311:21 amRNSResult of AGM
25th Nov 20138:46 amRNSUpdate and Notice of AGM
5th Nov 20137:00 amRNSDirectorate Change, Extension of Debt facilities
16th Oct 20137:00 amRNSCompletion of Snorkel Contribution
7th Oct 201310:27 amRNSResult of General Meeting
1st Oct 20134:35 pmRNSPrice Monitoring Extension
30th Sep 20137:00 amRNSInterim Results
26th Sep 20134:40 pmRNSSecond Price Monitoring Extn
26th Sep 20134:35 pmRNSPrice Monitoring Extension
20th Sep 20137:00 amRNSDisposal of Powered Access Division and GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.